T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Consumer Discretionary | 14.05% |
| 3 | Financials | 13.42% |
| 4 | Industrials | 12.52% |
| 5 | Technology | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Buckle
BKE
$2.33B
| $6.35M | ﹤0.01% |
120,862
-9,900
| -8% | -$486K |
|
1427
OGE Energy
OGE
$9.69B
| $6.18M | ﹤0.01% |
174,198
-407,210
| -70% | -$14.7M |
|
1428
XPO
XPO
$24.7B
| $6.17M | ﹤0.01% |
436,158
-37,588
| -8% | -$496K |
|
|
MASI
1429
DELISTED
Masimo
MASI
| $5.97M | ﹤0.01% |
226,530
-19,800
| -8% | -$489K |
|
|
FSYS
1430
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $5.95M | ﹤0.01% |
543,710
+1,400
| +0.3% | +$13.5K |
|
1431
BHP
BHP
$222B
| $5.87M | ﹤0.01% |
146,649
+11,235
| +8% | +$518K |
|
|
ETRM
1432
DELISTED
EnteroMedics Inc.
ETRM
| $5.82M | ﹤0.01% |
3,900
| – | – |
|
1433
Hyster-Yale Materials Handling
HY
$614M
| $5.71M | ﹤0.01% |
77,994
+200
| +0.3% | +$14.9K |
|
1434
Bio-Rad Laboratories Class A
BIO
$9.68B
| $5.7M | ﹤0.01% |
47,290
-3,400
| -7% | -$391K |
|
|
INFO
1435
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $5.64M | ﹤0.01% |
213,600
| – | – |
|
1436
Opko Health
OPK
$1.04B
| $5.63M | ﹤0.01% |
563,900
+111,300
| +25% | +$953K |
|
1437
Oil States International
OIS
$526M
| $5.54M | ﹤0.01% |
113,330
-12,500
| -10% | -$676K |
|
1438
Lexicon Pharmaceuticals
LXRX
$1.04B
| $5.53M | ﹤0.01% |
867,656
-10,428
| -1% | -$84.1K |
|
1439
Paylocity
PCTY
$8.1B
| $5.47M | ﹤0.01% |
209,700
+1,800
| +0.9% | +$45.2K |
|
|
QEP
1440
DELISTED
QEP RESOURCES, INC.
QEP
| $5.46M | ﹤0.01% |
269,840
-2,000
| -0.7% | -$46.6K |
|
1441
Urban Outfitters
URBN
$6.63B
| $5.46M | ﹤0.01% |
155,280
| – | – |
|
|
NAUH
1442
DELISTED
National American University Holdings, Inc.
NAUH
| $5.44M | ﹤0.01% |
2,024,543
+400
| +0% | +$1.2K |
|
1443
IQVIA
IQV
$39.8B
| $5.42M | ﹤0.01% |
92,100
| – | – |
|
1444
Erie Indemnity
ERIE
$13.5B
| $5.42M | ﹤0.01% |
59,700
-800
| -1% | -$68.2K |
|
|
STRI
1445
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
| $5.39M | ﹤0.01% |
1,310,459
+1,907
| +0.1% | +$7.25K |
|
1446
Advance Auto Parts
AAP
$3.23B
| $5.35M | ﹤0.01% |
33,578
-951
| -3% | -$140K |
|
1447
Standex International
SXI
$4B
| $5.26M | ﹤0.01% |
68,100
+3,700
| +6% | +$282K |
|
|
AJRD
1448
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $5.26M | ﹤0.01% |
287,510
-3,900
| -1% | -$65.3K |
|
|
AKAO
1449
DELISTED
Achaogen Inc
AKAO
| $5.15M | ﹤0.01% |
394,600
| – | – |
|
|
CYBE
1450
DELISTED
Cyberoptics Corp
CYBE
| $5.15M | ﹤0.01% |
535,583
-211,217
| -28% | -$1.97M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.